Pediatric ID News

Moderna said Monday that data from a phase 2/3 trial showed that its bivalent COVID-19 booster shot triggers a higher antibody response against SARS-CoV-2 omicron subvariants than its original vaccine.

SARS-CoV-2-related neurologic effects endured among children and adolescents in the United States who were hospitalized in 2021 for COVID-19 or multisystem inflammatory syndrome, researchers reported in JAMA Neurology.

Boston-area school districts that lifted mask mandates earlier this year experienced nearly 45 more cases of COVID-19 per 1,000 students and staff than school districts that kept their mandates in place, a study found.

Contact tracing and exposure investigation have helped to mitigate the spread of monkeypox virus in Massachusetts, where the first U.S. case in the current outbreak was detected, a study published in Annals of Internal Medicine found.

The Asian mosquito Anopheles stephensi, linked to a 40-fold increase in malaria cases in Djibouti over the last decade, has been blamed for an unprecedented dry-season malaria outbreak in Ethiopia, according to a study.

WASHINGTON — Although adenovirus infection has been widely implicated in an outbreak of acute, severe hepatitis in children, data presented at The Liver Meeting found no “singular definitive etiology” for these cases.

Children aged younger than 8 years are at an elevated risk for monkeypox complications and should be considered a high-risk group, according to a review article published in The Pediatric Infectious Disease Journal.

Globally, routine vaccination coverage among infants plummeted to a 13-year low in 2021, according to data published Thursday in MMWR.

Pfizer reported topline data from a phase 3 trial of its respiratory syncytial virus vaccine for pregnant women, which showed high vaccine efficacy in newborns.

Common childhood infections have returned following an interruption caused by the COVID-19 pandemic, including respiratory syncytial virus, which has caused a recent surge in the United States. Healio spoke with Mary T. Caserta, MD, a professor of infectious diseases in the department of pediatrics at the University of Rochester Medical Center, about what physicians can expect from RSV.